{
    "Trade/Device Name(s)": [
        "cobas pure integrated solutions",
        "Glucose HK Gen.3",
        "ISE indirect Na for Gen.2",
        "ONLINE DAT Methadone II",
        "Elecsys TSH"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K220134",
    "Predicate Device Reference 510(k) Number(s)": [
        "K060373",
        "K191899"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CFR",
        "JGS",
        "JLW",
        "DJR",
        "JJE"
    ],
    "Summary Letter Date": "July 1, 2022",
    "Summary Letter Received Date": "July 5, 2022",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "toxicology",
        "endocrine"
    ],
    "Analyte(s)": [
        "Glucose",
        "Sodium",
        "Methadone",
        "Thyrotropin (TSH)"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine",
        "Cerebrospinal fluid"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Li-Heparin Plasma tube",
        "K2-EDTA tube",
        "K3-EDTA tube"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas pure integrated solutions",
        "Roche/Hitachi cobas c systems",
        "cobas c 303 analytical unit",
        "cobas e 402 immunoassay analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Spectrophotometry",
        "Ion-selective electrode",
        "Kinetic interaction of microparticles in solution (KIMS)",
        "Electrochemiluminescence immunoassay (ECLIA)"
    ],
    "Methodologies": [
        "Quantitative analysis",
        "Qualitative analysis",
        "Semiquantitative analysis",
        "Sandwich immunoassay"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Assay",
        "Reagent",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for Roche cobas pure integrated solutions system and representative clinical chemistry and immunochemistry assays including glucose, sodium, methadone, and TSH",
    "Indications for Use Summary": "Automated analyzer for qualitative, semiquantitative, and quantitative clinical chemistry and immunochemistry assays as well as ion selective measurements; specific assays used for diagnosis and management of carbohydrate metabolism disorders, electrolyte imbalances, methadone detection, and thyroid/pituitary disorders",
    "fda_folder": "Clinical Chemistry"
}